跳至主要内容
临床试验/NCT02086474
NCT02086474已完成4 期

Daily Activity Quantification and Gait Pattern Analysis Before and After Intra-articular Injection of Viscosupplement Among Hip Osteoarthritis Patients

Laval University1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
38
试验地点
1
主要终点
Change in hip flexion-extension range of motion

研究概览

简要总结

The objective of this study is to assess the changes in daily physical activity and gait pattern, following a viscosupplement injection among a population who is suffering from hip osteoarthritis. A kinetic and kinematic gait analysis, an Actigraph activity monitor, a functional Timed-Stair-Test and two questionnaires (Medical Outcome Study Short-Form36 (MOS-SF36), Hip disability and Osteoarthritis Outcome Score (HOOS)) about how the pathology affects the quality of life, will be use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • From 45 years old to 65 years old
  • Clinically symptomatic moderate or severe hip osteoarthritis (Tönnis Grade II to III)
  • Capacity to keep steady upright position and walking during 15 minutes
  • Body mass index < 40kg/m2

排除标准

  • Bilateral hip osteoarthritis
  • No broken hip or leg during the last 12 months
  • Bone necrosis
  • Rheumatoid arthritis, articular chondrocalcinosis, metabolic bone disease, psoriasis, gout, active infection
  • Per os corticosteroid treatment
  • Corticosteroid injection < 3 months
  • Viscosupplement injection < 6 months
  • Hypersensitivity to hyaluronic acid products
  • Planed surgery during study duration
  • Physical or mental disability to fill in questionnaires and/or to participate to follow-up

研究组 & 干预措施

Hyaluronan

Experimental

Hyaluronan acid Neovisc : one 6cc (viscosupplement) intra-articular injection

干预措施: Hyaluronan (Drug)

Bupivacaine

Placebo Comparator

one Marcain extra-capsular injection

干预措施: Bupivacaine (Drug)

结局指标

主要结局

Change in hip flexion-extension range of motion

时间窗: Change from Baseline at 6 months

Subtraction between maximum and minimum flexion measured with motion capture system during gait

Change in daily physical activity

时间窗: Change from Baseline at 6 months

Intensity and duration of the daily physical activity measured with pedometer

次要结局

  • Change in hip pain(change from Baseline at 6 months)
  • Change in quality of life(Change from Baseline at 6 months)
  • Change in walking cadence(Change from Baseline at 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Philippe Corbeil

PhD

Laval University

研究点 (1)

Loading locations...

相似试验

Daily Activity and Gait Analysis After... | 临床试验